Dimethyl fumarate therapy is associated with increased IL10+B regulatory cell subsets in patients with multiple sclerosis

被引：0
|
作者：
Staun-Ram, E. [1 ]
Najjar, E. [1 ]
Miller, A. [1 ,2 ,3 ]
机构：
[1] Technion Israel Inst Technol, Rappaport Fac Med, Neuroimmunol, Haifa, Israel
[2] Carmel Hosp, Neuroimmunol Unit, Haifa, Israel
[3] Carmel Hosp, Multiple Sclerosis Ctr, Haifa, Israel
来源：
MULTIPLE SCLEROSIS JOURNAL | 2016年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1159
引用
收藏
页码：603 / 604
页数：2
相关论文
共 50 条
  • [1] Fingolimod therapy modulates circulating B cell composition, increases B regulatory subsets and production of IL-10 and TGFβ in patients with Multiple Sclerosis
    Blumenfeld, Shiri
    Staun-Ram, Elsebeth
    Miller, Ariel
    [J]. JOURNAL OF AUTOIMMUNITY, 2016, 70 : 40 - 51
  • [2] Dimethyl Fumarate Treatment Mediates an Anti-Inflammatory Shift in B Cell Subsets of Patients with Multiple Sclerosis
    Li, Rui
    Rezk, Ayman
    Ghadiri, Mathab
    Luessi, Felix
    Zipp, Frauke
    Li, Hulun
    Giacomini, Paul S.
    Antel, Jack
    Bar-Or, Amit
    [J]. JOURNAL OF IMMUNOLOGY, 2017, 198 (02): : 691 - 698
  • [3] Effect of dimethyl fumarate on lymphocyte subsets in patients with relapsing multiple sclerosis
    Buckle, Guy
    Bandari, Daniel
    Greenstein, Jeffrey
    Gudesblatt, Mark
    Khatri, Bhupendra
    Kita, Mariko
    Repovic, Pavle
    Riser, Emily
    Weinstock-Guttman, Bianca
    Thrower, Ben
    Loring, Sherrill
    Riester, Katherine
    Everage, Nick
    Prada, Claudia
    Koulinska, Irene
    Mann, Monica
    [J]. MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2020, 6 (02)
  • [4] Dimethyl fumarate treatment of relapsing-remitting multiple sclerosis influences B-cell subsets
    Lundy, Steven K.
    Wu, Qi
    Wang, Qin
    Dowling, Catherine A.
    Taitano, Sophina H.
    Mao, Guangmei
    Mao-Draayer, Yang
    [J]. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2016, 3 (02):
  • [5] Liver injury associated with dimethyl fumarate in multiple sclerosis patients
    Munoz, Monica A.
    Kulick, Corrinne G.
    Kortepeter, Cindy M.
    Levin, Robert L.
    Avigan, Mark I.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (14) : 1947 - 1949
  • [6] Dimethyl fumarate treatment alters circulating T helper cell subsets in multiple sclerosis
    Gross, Catharina C.
    Schulte-Mecklenbeck, Andreas
    Klinsing, Svenja
    Posevitz-Fejfar, Anita
    Wiendl, Heinz
    Klotz, Luisa
    [J]. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2016, 3 (01):
  • [7] Thymosin-α1 expands deficient IL-10-producing regulatory B cell subsets in relapsing-remitting multiple sclerosis patients
    Giacomini, Elena
    Rizzo, Fabiana
    Etna, Marilena P.
    Cruciani, Melania
    Mechelli, Rosella
    Buscarinu, Maria Chiara
    Pica, Francesca
    D'Agostini, Cartesio
    Salvetti, Marco
    Coccia, Eliana M.
    Severa, Martina
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (02) : 127 - 139
  • [8] Loss of IL-10 secretion by regulatory B lymphocytes in multiple sclerosis patients
    Laure Michel
    Nicolas Degauque
    Alexandra Garcia
    Marion Salou
    Annie Elong Ngono
    Jean-Paul Soulillou
    David Laplaud
    Sophie Brouard
    [J]. Journal of Translational Medicine, 9 (Suppl 2)
  • [9] Altered adipokine levels are associated with dimethyl fumarate treatment in multiple sclerosis patients
    Baharnoori, Moogeh
    Wilson, Ryan
    Saxena, Shrishti
    Gonzalez, Cindy T.
    Sotiropoulos, Marinos G.
    Keyhanian, Kiandokht
    Healy, Brian C.
    Chitnis, Tanuja
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 56
  • [10] Increased Multiple Sclerosis disease activity in patients transitioned from fingolimod to dimethyl fumarate
    Delgado, Silvia
    Hernandez, Jeffrey
    Tornes, Leticia
    Rammohan, Kottil
    [J]. NEUROLOGY, 2019, 92 (15)
12345